Filing Details

Accession Number:
0001209191-15-024956
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-03-11 08:38:52
Reporting Period:
2015-03-06
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 08:38:52
Original Submission Date:
2015-03-10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1564955 Greg Madison C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-06 6,380 $12.53 110,043 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Form 4 originally filed on March 10, 2015 is being amended to revise Column 4 to state that the securities were acquired and not disposed of.
  2. Includes 73,875 shares of restricted stock.